IPIXInnovation Pharmaceuticals Inc.

About Innovation Pharmaceuticals Inc. (IPIX)

Innovation Pharmaceuticals Inc. (IPIX) is a Biotechnology company headquartered in Wakefield, MA, United States whose shares trade over-the-counter on the Expert Market tier.

An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers.

Products and services

Clinical stage development -pharmaceuticals. We are focused on antiviral, anti-inflammatory, Dermatology, GI and cancer treatments.

IPIX key facts

Ticker symbol

IPIX

Market tier

Expert Market

Sector

Healthcare

Industry

Biotechnology

Headquarters

Wakefield, MA, United States

Country of incorporation

US

Year of incorporation

2005

Employees

4

Estimated market cap

$106.6K (as of Apr 16, 2025)

Shares outstanding

532,947,433

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

6/30

Latest filing

8K Report (Jan 31, 2024)

Innovation Pharmaceuticals Inc. leadership

• Leo Ehrlich — CEO, CFO

Explore more: Biotechnology stocks · Healthcare sector · Expert Market stocks · OTC stocks starting with I